This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Selective Norepinephrine Reuptake Inhibitor (NBIX)
Neurocrine Biosciences, Inc.
Drug Names(s): sNRI
Description: Neurocrine's selective norepinephrine reuptake inhibitor (sNRI) is highly selective for acting at its target and has not shown off-target effects. The compound also has not shown the cytochrome P450 2D6 metabolic risks associated with Strattera, another member of the sNRI class of drugs.
Selective Norepinephrine Reuptake Inhibitor (NBIX) News
Additional information available to subscribers only: